World Pharma News Digest - 31.03.2014
4 views
Skip to first unread message
Ruslan David
Mar 31, 2014, 6:00:21 AM3/31/14
to worldph...@googlegroups.com
AstraZeneca and MRC enter strategic collaboration
AstraZeneca and the Medical Research Council (MRC) today announced that they have entered into a groundbreaking collaboration aimed at better understanding the mechanisms of human disease. The collaboration will see the creation of a joint research facility at AstraZeneca's new R&D centre in Cambridge in the UK.
Read more...
http://www.worldpharmanews.com/astrazeneca/2740-astrazeneca-and-mrc-enter-strategic-collaboration
Novo Nordisk launches 'Cities Changing Diabetes' to fight urban diabetes
Novo Nordisk today announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge. The 'Cities Changing Diabetes' programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow.
Read more...
http://www.worldpharmanews.com/novonordisk/2739-novo-nordisk-launches-cities-changing-diabetes-to-fight-urban-diabetes
Where do you start when developing a new medicine?
A pioneering public-private research initiative between GSK, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute is to harness the power of 'big data' and genome sequencing to improve the success rate for discovering new medicines. The new Centre for Therapeutic Target Validation (CTTV) will aim to address a wide range of human diseases and will share its data openly in the interests of accelerating drug discovery.
Read more...
http://www.worldpharmanews.com/gsk/2738-where-do-you-start-when-developing-a-new-medicine
First comprehensive atlas of human gene activity released
A large international consortium of researchers has produced the first comprehensive, detailed map of the way genes work across the major cells and tissues of the human body. The findings describe the complex networks that govern gene activity, and the new information could play a crucial role in identifying the genes involved with disease.
Read more...
http://www.worldpharmanews.com/research/2737-first-comprehensive-atlas-of-human-gene-activity-released
New technique brings us closer to HIV and hepatitis C vaccines
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking new research. Professor Eric Gowans from the University's Discipline of Surgery, based at the Basil Hetzel Institute at the Queen Elizabeth Hospital, has submitted a patent application for what he describes as a relatively simple but effective technique to stimulate the body's immune system response, thereby helping to deliver the vaccine.
Read more...
http://www.worldpharmanews.com/research/2736-new-technique-brings-us-closer-to-hiv-and-hepatitis-c-vaccines
Shifting evolution into reverse promises cheaper, greener way to make new drugs
This alternative approach to creating artificial organic molecules, called bioretrosynthesis, was first proposed four years ago by Brian Bachmann, associate professor of chemistry at Vanderbilt University. Now Bachmann and a team of collaborators report that they have succeeded in using the method to produce the HIV drug didanosine. The proof of concept experiment is described in a paper published online March 23 by the journal Nature Chemical Biology.
Read more...
http://www.worldpharmanews.com/research/2735-shifting-evolution-into-reverse-promises-cheaper-greener-way-to-make-new-drugs
PharmaNews.eu / Latest News
AstraZeneca and MRC enter strategic collaboration
http://www.pharmanews.eu/astrazeneca/1426-astrazeneca-and-mrc-enter-strategic-collaboration
Where do you start when developing a new medicine?
http://www.pharmanews.eu/gsk/1425-where-do-you-start-when-developing-a-new-medicine
New online tool helps patient advocates navigate medicines development and evaluation process
http://www.pharmanews.eu/lilly/1424-new-online-tool-helps-patient-advocates-navigate-medicines-development-and-evaluation-process
New drug raises potential for cancer treatment revolution
http://www.pharmanews.eu/research-and-development/1423-new-drug-raises-potential-for-cancer-treatment-revolution
HIMSS Europe Online Matchmaking at WoHIT 2014
http://www.pharmanews.eu/conferences-and-events/1422-himss-europe-online-matchmaking-at-wohit-2014
New approach makes cancer cells explode
http://www.pharmanews.eu/research-and-development/1421-new-approach-makes-cancer-cells-explode
Novartis reports data at EBCC-9 for secondary survival endpoint of Afinitor trial in HR+/HER2- advanced breast cancer
http://www.pharmanews.eu/novartis/1420-novartis-reports-data-at-ebcc-9-for-secondary-survival-endpoint-of-afinitor-trial-in-hrher2-advanced-breast-cancer
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
AstraZeneca and the Medical Research Council (MRC) today announced that they have entered into a groundbreaking collaboration aimed at better understanding the mechanisms of human disease. The collaboration will see the creation of a joint research facility at AstraZeneca's new R&D centre in Cambridge in the UK.
Read more...
http://www.worldpharmanews.com/astrazeneca/2740-astrazeneca-and-mrc-enter-strategic-collaboration
Novo Nordisk launches 'Cities Changing Diabetes' to fight urban diabetes
Novo Nordisk today announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge. The 'Cities Changing Diabetes' programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow.
Read more...
http://www.worldpharmanews.com/novonordisk/2739-novo-nordisk-launches-cities-changing-diabetes-to-fight-urban-diabetes
Where do you start when developing a new medicine?
A pioneering public-private research initiative between GSK, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute is to harness the power of 'big data' and genome sequencing to improve the success rate for discovering new medicines. The new Centre for Therapeutic Target Validation (CTTV) will aim to address a wide range of human diseases and will share its data openly in the interests of accelerating drug discovery.
Read more...
http://www.worldpharmanews.com/gsk/2738-where-do-you-start-when-developing-a-new-medicine
First comprehensive atlas of human gene activity released
A large international consortium of researchers has produced the first comprehensive, detailed map of the way genes work across the major cells and tissues of the human body. The findings describe the complex networks that govern gene activity, and the new information could play a crucial role in identifying the genes involved with disease.
Read more...
http://www.worldpharmanews.com/research/2737-first-comprehensive-atlas-of-human-gene-activity-released
New technique brings us closer to HIV and hepatitis C vaccines
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking new research. Professor Eric Gowans from the University's Discipline of Surgery, based at the Basil Hetzel Institute at the Queen Elizabeth Hospital, has submitted a patent application for what he describes as a relatively simple but effective technique to stimulate the body's immune system response, thereby helping to deliver the vaccine.
Read more...
http://www.worldpharmanews.com/research/2736-new-technique-brings-us-closer-to-hiv-and-hepatitis-c-vaccines
Shifting evolution into reverse promises cheaper, greener way to make new drugs
This alternative approach to creating artificial organic molecules, called bioretrosynthesis, was first proposed four years ago by Brian Bachmann, associate professor of chemistry at Vanderbilt University. Now Bachmann and a team of collaborators report that they have succeeded in using the method to produce the HIV drug didanosine. The proof of concept experiment is described in a paper published online March 23 by the journal Nature Chemical Biology.
Read more...
http://www.worldpharmanews.com/research/2735-shifting-evolution-into-reverse-promises-cheaper-greener-way-to-make-new-drugs
PharmaNews.eu / Latest News
AstraZeneca and MRC enter strategic collaboration
http://www.pharmanews.eu/astrazeneca/1426-astrazeneca-and-mrc-enter-strategic-collaboration
Where do you start when developing a new medicine?
http://www.pharmanews.eu/gsk/1425-where-do-you-start-when-developing-a-new-medicine
New online tool helps patient advocates navigate medicines development and evaluation process
http://www.pharmanews.eu/lilly/1424-new-online-tool-helps-patient-advocates-navigate-medicines-development-and-evaluation-process
New drug raises potential for cancer treatment revolution
http://www.pharmanews.eu/research-and-development/1423-new-drug-raises-potential-for-cancer-treatment-revolution
HIMSS Europe Online Matchmaking at WoHIT 2014
http://www.pharmanews.eu/conferences-and-events/1422-himss-europe-online-matchmaking-at-wohit-2014
New approach makes cancer cells explode
http://www.pharmanews.eu/research-and-development/1421-new-approach-makes-cancer-cells-explode
Novartis reports data at EBCC-9 for secondary survival endpoint of Afinitor trial in HR+/HER2- advanced breast cancer
http://www.pharmanews.eu/novartis/1420-novartis-reports-data-at-ebcc-9-for-secondary-survival-endpoint-of-afinitor-trial-in-hrher2-advanced-breast-cancer
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
Reply all
Reply to author
Forward
0 new messages